迈威生物：2025年年度业绩预亏公告

Core Viewpoint - Maiwei Biotech announced an expected narrowing of losses for the fiscal year 2025, projecting a net profit attributable to the parent company of between -900 million to -994.5 million yuan, compared to a loss of -1,043.92 million yuan in the previous year [2] Financial Performance - The company anticipates a net profit attributable to the parent company, excluding non-recurring gains and losses, to be between -905 million to -999.5 million yuan [2]